Use of granulocyte colony-stimulating factor plus plerixafor for stem cell mobilization is cost-effective in pretreated patients with non-Hodgkin lymphoma.
Dennis L. Lambert, PhD
Advertisement
Articles by Dennis L. Lambert, PhD
Advertisement
Latest Updated Articles
- Economic Evaluation of Plerixafor for Stem Cell Mobilization
Published: January 19th 2012 | Updated:
Advertisement
Advertisement
